Specifications
Immunogen
E. coli expressed, recombinant human LT-alpha.
Applications
Application Notes
ELISA: 0.25-1.0 μg/ml(as a detection antibody); Flow cytometric: 0.25 μg/106 cells
Target
Alternative Names
LT; TNFB; TNFSF1
Product Background
Antigen Description
Lymphotoxin-alpha (LT-alpha), also known as tumor necrosis factor-beta (TNF-beta), is a potent lymphoid factor that exerts cytotoxic effects on a wide range of tumor cells and certain other target cells. LT-alpha possesses a signal peptide sequence and is a secreted protein however, LT-alpha is also present on the surface of activated T, B and LAK cells as a complex with LT-beta. Bioactive LT-alpha exists as a homotrimer.
Citations
Have you cited CABT-WN1233 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Laverde, D; Wobser, D; et al. Synthetic Teichoic Acid Conjugate Vaccine against Nosocomial Gram-Positive Bacteria. PLOS ONE 9:-(2014).
Yang, LY; Shen, SC; et al. Hispolon inhibition of inflammatory apoptosis through reduction of iNOS/NO production via HO-1 induction in macrophages. JOURNAL OF ETHNOPHARMACOLOGY 156:61-72(2014).